B-Myb, cancer, senescence, and MicroRNAs

Cancer Research

Volumn 71, Issue 16, 2011, Pages 5370-5373

  Martinez, Ivan ^a   DiMaio, Daniel ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN B MYB; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL AGING; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ANALYSIS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN RNA BINDING; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CELL AGING; CELL CYCLE PROTEINS; CELL PROLIFERATION; HUMANS; MICRORNAS; NEOPLASMS; PROMOTER REGIONS, GENETIC; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANS-ACTIVATORS;

EID: 80051677647     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1044     Document Type: Review

References (44)

1. Joaquin M, Watson RJ. Cell cycle regulation by the B-Myb transcription factor. Cell Mol Life Sci 2003;60:2389-401. (Pubitemid 37487259)
2. Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999;18:3017-33. (Pubitemid 29276541)
3. Roussel M, Saule S, Lagrou C, Rommens C, Beug H, Graf T, et al. Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature 1979;281:452-5. (Pubitemid 10244265)
4. Shen-Ong GL. The myb oncogene. Biochim Biophys Acta 1990;1032:39-52.
5. Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S, et al. Isolation of human cDNA clones of myb-related genes, A-myb and Bmyb. Nucleic Acids Res 1988;16:11075-89. (Pubitemid 19008458)
6. Sala A. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 2005;41:2479-84.
7. Lam EW, Bennett JD, Watson RJ. Cell-cycle regulation of human Bmyb transcription. Gene 1995;160:277-81.
8. Tanaka Y, Patestos NP, Maekawa T, Ishii S. B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem 1999;274:28067-70.
9. Ness SA. Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol Dis 2003;31:192-200.
10. Brandt TL, Fraser DJ, Leal S, Halandras PM, Kroll AR, Kroll DJ. c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter. J Biol Chem 1997;272:6278-84. (Pubitemid 27118100)
11. Gualdrini F, Corvetta D, Cantilena S, Chayka O, Tanno B, Raschellà G, et al. Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop. Oncotarget 2010;1:278-88.
12. Foos G, Natour S, Klempnauer KH. TATA-box dependent transactivation of the human HSP70 promoter by Myb proteins. Oncogene 1993;8:1775-82. (Pubitemid 23212409)
13. Sala A, Saitta B, De Luca P, Cervellera MN, Casella I, Lewis RE, et al. B-MYB transactivates its own promoter through SP1-binding sites. Oncogene 1999;18:1333-9. (Pubitemid 29094885)
14. Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1/S and G2/M transcription. EMBO J 2004;23:4615-26. (Pubitemid 39657861)
15. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, et al. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 2007;26:539-51. (Pubitemid 46779093)
16. Schmit F, Korenjak M, Mannefeld M, Schmitt K, Franke C, von Eyss B, et al. LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes. Cell Cycle 2007;6:1903-13. (Pubitemid 47327909)
17. Knight AS, Notaridou M, Watson RJA. A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells. Oncogene 2009;28:1737-47.
18. Mannefeld M, Klassen E, Gaubatz S. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells. Cancer Res 2009;69:4073-80.
19. Marhamati DJ, Sonenshein GE. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and downregulates promoter activity of type I collagen genes. J Biol Chem 1996;271:3359-65.
20. Masselink H, Vastenhouw N, Bernards R. B-myb rescues ras-induced premature senescence, which requires its transactivation domain. Cancer Lett 2001;171:87-101. (Pubitemid 32727359)
21. Yamauchi T, Ishidao T, Nomura T, Shinagawa T, Tanaka Y, Yonemura S, et al. A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. EMBO J 2008;27:1852-62. (Pubitemid 351960212)
22. Johnson LR, Johnson TK, Desler M, Luster TA, Nowling T, Lewis RE, et al. Effects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300. J Biol Chem 2002;277:4088-97. (Pubitemid 34968666)
23. Robinson C, Light Y, Groves R, Mann D, Marias R, Watson R. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle. Oncogene 1996;12:1855-64. (Pubitemid 26154657)
24. Charrasse S, Carena I, Brondani V, Klempnauer KH, Ferrari S. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway. Oncogene 2000;19:2986-95. (Pubitemid 30389089)
25. Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL, et al. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc Natl Acad Sci U S A 1994;91:10079-83. (Pubitemid 24311952)
26. Sala A, Casella I, Bellon T, Calabretta B, Watson RJ, Peschle C. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. J Biol Chem 1996;271:9363-7. (Pubitemid 26139921)
27. Joaquin M, Watson RJ. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57 (KIP2) by interacting with its cyclin-binding domain. J Biol Chem 2003;278:44255-64. (Pubitemid 37377170)
28. Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, Yaron Y, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002;62:6803-7. (Pubitemid 35424062)
29. Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, et al. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Cancer Res 1999;59:3365-8. (Pubitemid 29334493)
30. Thorner AR, Hoadley KA, Parker JS, Winkel S, Millikan RC, Perou CM. In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene 2009;28:742-51.
31. Arsura M, Introna M, Passerini F, Mantovani A, Golay J. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood 1992;79:2708-16.
32. Sala A, Calabretta B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl Acad Sci U S A 1992;89:10415-9.
33. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, et al. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J Biol Chem 2000;275:21055-60. (Pubitemid 30481795)
34. Grassilli E, Salomoni P, Perrotti D, Franceschi C, Calabretta B. Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. Cancer Res 1999;59:2451-6. (Pubitemid 29242296)
35. Lang G, Gombert WM, Gould HJ. A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene. Immunology 2005;114:25-36. (Pubitemid 40030290)
36. Schwab R, Bussolari R, Corvetta D, Chayka O, Santilli G, Kwok JM, et al. Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk. Oncogene 2008;27:2929-33. (Pubitemid 351620448)
37. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76. (Pubitemid 40311739)
38. Johung K, Goodwin EC, DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 2007;81:2102-16.
39. Huang Y, Wu J, Li R, Wang P, Han L, Zhang Z, et al. B-MYB delays cell aging by repressing p16 (INK4a) transcription. Cell Mol Life Sci 2011;68:893-901.
40. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 2000;20:5797-807. (Pubitemid 30613029)
41. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A 2011;108:522-7.
42. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
43. DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 2003;77:1551-63. (Pubitemid 36055574)
44. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007;104:15805-10. (Pubitemid 350035380)